Phio Executives Lead Insider Buying Surge Amid Stock Plunge, Signals Confidence in Future Breakthroughs
Phio Pharmaceuticals’ insider buying surge shows executive confidence amid steep share drops; RSU conversions hint at a long‑term rebound potential.
3 minutes to read
